Guaranteeing the Continuity of the Care Pathway for the Elderly Patient: Evaluation of a Territorial Approach of Clinical Pharmacy (CONPARMED)

Rennes University Hospital

Status: Completed

Conditions: Medication Reconciliation at Discharge

Treatments: Other: medication reconciliation

Study type: Observational

Funder types: Other

Identifiers

NCT04018781

35RC19_30022

2019-A00455-52 (Other Identifier)

Details and patient eligibility

About

In the context of the ageing of the French population, drug iatrogeny in the elderly is a major public health issue, responsible for approximately 7,500 deaths per year and 3.4% of hospitalizations among patients aged 65 and over.

The interest of the Medication Reconciliation (MR) in reducing medication errors and unintentional discrepancies in prescriptions at transition points in patients' medication care pathways no longer seems to be in doubt both in France and abroad.

On the other hand, the literature on the clinical impact of these drug errors (i. e. occurrence of an adverse drug event (ADE) or readmission rates) is currently limited in France and presents variable results abroad.

Full description

The medication reconciliation implementation mobilizes human resources (pharmacists, pharmacy technician, nurses...) and constitutes an investment for healthcare institutions. However, the resulting improvement in patients' health status (and the potential reduction in ADEs) could reduce their care consumption and thus reduce costs from a healthcare system perspective. We therefore propose to assess the cost-effectiveness of this care strategy.

Finally, we will study the impact of the MR deployment on existing professional organizations, both in hospital and between community healthcare professionals and hospital as well as its conditions of implementation.

Enrollment: 443 patients

Sex: All

Ages: 65+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria :

• Patient > 65 years old
• Patient hospitalized inside one of the thirteen wards in the 6 hospitals participating in the study
• Informed consent given

Non inclusion and Exclusion Criteria :

• Patients in palliative care
• Persons deprived of their liberty

Trial design

443 participants in 2 patient groups

MR group

Description:

Patients who benefit from a full process of medication reconciliation (entrance and discharge) before being discharged to home.

Treatment:

Other: medication reconciliation

Control group

Description:

Patients who benefitted from a medication reconciliation at entrance only before being discharged to home.

Treatment:

Other: medication reconciliation